Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19

被引：0
|
作者：
Cook, Michael Roderick
Dykes, Kaitlyn C.
White, Katherine
Ahn, Jaeil
Cobb, Nathan
Lai, Catherine
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138941
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19
    Cook, Michael R.
    Dykes, Kaitlyn
    White, Katherine
    Desale, Sameer
    Agrawal, Rajeev
    Fernandez, Stephen
    Huang, Xu
    Cobb, Nathan K.
    Lai, Catherine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : E452 - E458
  • [2] COVID-19 in patients with hematologic malignancy
    Langerbeins, Petra
    Hallek, Michael
    BLOOD, 2022, 140 (03) : 236 - 252
  • [3] Clinical Outcomes in Patients With COVID-19 and Hematologic Disease
    Aleshina, Olga A.
    Zakurdaeva, Kristina
    Vasileva, Anastasia N.
    Dubov, Sergey K.
    Dubov, Vitaly S.
    Vorobyev, Vladimir I.
    Butaev, Lev S.
    Sukhareva, Alena M.
    Gavrilova, Lubov, V
    Toropova, Inessa Yu.
    Popova, Marina O.
    Siniaev, Aleksandr A.
    Kulagin, Aleksandr D.
    Kaplanov, Kamil D.
    Petrenko, Andrei A.
    Ochirova, Oksana I.
    Karpova, Alina
    Chelysheva, Ekaterina Yu.
    Turkina, Anna G.
    Gurianova, Margarita A.
    Al-Radi, Liubov S.
    Gilyazitdinova, Elena A.
    Egorova, Elena K.
    Chabaeva, Yulia A.
    Kulikov, Sergey M.
    Sveshnikova, Yulia, V
    Kunst, Mikhail A.
    Shuvaev, Vasily
    Rakhmani, Anzhelika F.
    Panteleeva, Olga L.
    Grishunina, Maria E.
    Samoylova, Olga S.
    Vorontsova, Ekaterina
    Baryshnikova, Daria, V
    Parovichnikova, Elena N.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (08): : 589 - 598
  • [4] COVID-19 vaccine effectiveness in patients with hematologic malignancy
    Shah, Dimpy P.
    Shah, Pankil K.
    Thompson, Michael A.
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
  • [5] COVID-19 outcomes in patients with hematologic disease
    Florent Malard
    Alexis Genthon
    Eolia Brissot
    Zoe van de Wyngaert
    Zora Marjanovic
    Souhila Ikhlef
    Anne Banet
    Simona Lapusan
    Simona Sestilli
    Elise Corre
    Annalisa Paviglianiti
    Rosa Adaeva
    Fella M.’Hammedi-Bouzina
    Myriam Labopin
    Ollivier Legrand
    Rémy Dulery
    Mohamad Mohty
    Bone Marrow Transplantation, 2020, 55 : 2180 - 2184
  • [6] COVID-19 outcomes in patients with hematologic disease
    Malard, Florent
    Genthon, Alexis
    Brissot, Eolia
    van de Wyngaert, Zoe
    Marjanovic, Zora
    Ikhlef, Souhila
    Banet, Anne
    Lapusan, Simona
    Sestilli, Simona
    Corre, Elise
    Paviglianiti, Annalisa
    Adaeva, Rosa
    M'Hammedi-Bouzina, Fella
    Labopin, Myriam
    Legrand, Ollivier
    Dulery, Remy
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2020, 55 (11) : 2180 - 2184
  • [7] COVID-19 in vaccinated versus unvaccinated hematologic malignancy patients
    DeVoe, Catherine
    Pandey, Shraddha
    Shariff, Dayana
    Arora, Shagun
    Henrich, Timothy J.
    Yokoe, Deborah S.
    Langelier, Charles R.
    Servellita, Venice
    Chiu, Charles
    Miller, Steve
    Babik, Jennifer M.
    Chin-Hong, Peter
    Fung, Monica
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
  • [8] Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies
    Behrens, Elizabeth
    Timmermann, Anne
    Yerkan, Alexander
    Katz, Deborah A.
    Paner, Agne
    Larson, Melissa C.
    Kim, Seo-Hyun
    Jain, Shivi
    Gezer, Sefer
    Venugopal, Parameswaran
    Dehghan-Paz, Irene
    Rhee, Yoona
    Ustun, Celalettin
    Varma, Ankur
    Shammo, Jamile M.
    BLOOD, 2020, 136
  • [9] Impact of COVID-19 on patient care for hematologic malignancy
    Koyama, Taiji
    CANCER SCIENCE, 2022, 113 : 1318 - 1318
  • [10] Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies
    Chien, Kelly S.
    Peterson, Christine B.
    Young, Elliana
    Chihara, Dai
    Manasanch, Elizabet E.
    Ramdial, Jeremy L.
    Thompson, Philip A.
    BLOOD ADVANCES, 2023, 7 (19) : 5691 - 5697
12345